Abstract
Migraine and depression are recognized as comorbid disorders on the basis of several epidemiological data and on the possibility of shared mechanisms. On the other hand, there is a lack of studies concerning therapeutic strategies in patients with this comorbidity. The aim of this paper is to briefly review the literature about the migraine and depression comorbidity and on the putative common neurobiological mechanisms, as well to discuss the possible therapeutic options in treating patients with both disorders.
Similar content being viewed by others
References
Baskin SM, Lipchik GL, Smitherman TA (2006) Mood and anxiety disorders in chronic headache. Headache 46(Suppl 3):S76–S87
Radat F, Swendsen J (2004) Psychiatric comorbidity in migraine: a review. Cephalalgia 25:165–178
Lake AE, Rains JC, Penzien DB et al (2005) Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 45:493–506
Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327–1333
Breslau N (1998) Psychiatric comorbidity in migraine. Cephalagia 18(Suppl 22):56–61
Baskin SM, Smitherman TA (2009) Migraine and psychiatric disorders: comorbities, mechanisms, and clinical applications. Neurol Sci 30(Suppl 1):S61–S65
Finocchi C, Villani V, Casucci G (2010) Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurol Sci 31(Suppl 1):S95–S98
Wang SJ, Liu HC, Fuh JL et al (1999) Comorbidity of headaches and depression in the elderly. Pain 82(3):239–243
Lipton RB, Hamelsky SW, Kolodner KB et al (2000) Migraine, quality of life, and depression: a population-based case–control study. Neurology 55:629–635
Merikangas KR, Angst J, Isler H (1990) Migraine and psychopatology. Results of Zurich cohort study of young adults. Arch Gen Psychiatry 47:849–853
Breslau N, Schultz LR, Stewart WF et al (2000) Headache and major depression: is the association specific to migraine? Neurology 54:308–313
Swartz KL, Pratt LA, Armenian HK et al (2000) Mental disorders and the incidence of migraine headache in a community sample. Arch Gen Psychiatry 57:945–950
Patel NV, Bigal ME, Koloner KB et al (2004) Prevalence and impact of migraine and probable migraine in a health plan. Neurology 63:1432–1438
Mc Williams LA, Goodwin RD, Cox BJ (2004) Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 111:77–83
Fasmer OB, Oedegaard KJ (2001) Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry 2:149–155
Oedegaard KJ, Angst J, Neckelmann D et al (2005) Migraine aura without headache compared to migraine with aura in patients with affective disorders. J Headache Pain 6:378–386
Oedegaard KJ, Neckelmann D, Mykletun A (2006) Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The Hunt Study. Cephalalgia 26:1–6
Breslau N, Lipton RB, Stewart WF et al (2003) Comorbidity of migraine and depression. Neurology 60:1308–1312
Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 137:11–23
Antonaci F, Nappi G, Galli F et al (2011) Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain [Epub ahead of print]
Juhasz G, Zsombok T, Laszik A et al (2003) Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet 17:231–240
Todt U, Freudenberg J, Goebel I et al (2006) Variation of the serotonin receptor gene SLC6A4 in the susceptibility to migraine with aura. Neurology 67:1707–1709
Marziniak M, Mossner R, Schmitt A et al (2005) A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 64:157–159
Kotani K, Shimomura T, Shimomura F et al (2002) A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 42:893–895
Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1295–1300
Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180:305–313
Lotrich FE, Pollock BG (2004) Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Gen 14:121–129
Caspi A, Sugden K, Moffit TE et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389
Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with polymorphisms in the serotonin transporter gene regulatory region. Science 274:1527–1531
Sen s, Burmeister M, Ghosh D (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127:85–89
Perutka SJ, Price SC, Wilhoit TL et al (1998) Comorbid migraine wth aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NNcoI alleles. Mol Med 4:14–21
Seligman MEP (1975) Helplessness: on depression development and death. WH Freeman and Company, San Francisco
Lipton RB, Stewart WF, Diamond S et al (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657
Kessler RC, McGonagle KA, Zhao S (1994) Lifetime and 12-month prevalence of DSM-III R psychiatric disorder in the United States. Results from the National Comorbidity Survey. Arch Gen Psych 51:8–19
Peterlin BL, Katsnelson MJ, Calhoun AH (2009) The association between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen. Curr Pain Headache Rep 13(5):404–412
Martin VT, Behbehani M (2006) Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis—part I. Headache 46:3–23
Scher AI, Midgette LA, Lipton RRB (2008) Risk factors for headache chronification. Headache 48:16–25
Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache 46:1334–1343
Smitherman TA, Penzien DB, Maizels M (2008) Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep 12:224–229
Monroe SM, Harkness KL (2005) Life stress, the “kindling” hypothesis, and recurrence of depression: consideration from a life stress perspective. Psychol Rev 112:417–445
Tietjen GE, Brandes JL, Peterlin BL et al (2009) Allodynia in migraine: association with comorbid pain conditions. Hedache 49:1333–1344
Lovati C, D’Amico D, Bertora P (2009) Allodynia in migraine: frequent random association or unavoidable consequence? Expert Rev Neurother 9(3):395–408
Welch KMA, Nagesh V, Aurora SK et al (2001) Periaquiductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637
Videbech P, Ravnkilde B (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161:1957–1966
Barden N (2004) Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29:185–193
Peres MF, Sanchez DR, Seabra ML et al (2001) Hypotalamic involment in chronic migraine. J Neurol Neurosurg Psychiatry 71:747–751
Bigal ME, Lipton RB, Holland PR et al (2007) Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology 68:1851–1861
Miura H, Ozaki N, Sawada M et al (2008) A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11:198–209
Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools for psychiatric comorbidity in headache patients. Headache 46(suppl 3):S98–S109
Heckman BD, Holroyd KA, Himawan L et al (2009) Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study. Pain 146:56–64
Smitherman TA, Walters AB, Maizels M et al (2010) The use of antidepressants for headache prophylaxis. CNS Neurosci Ther 1–8
Evers S (2008) Treatment of migraine with prophylactic drugs. Expert Opin Pharmacother 9(15):2565–2573
Colombo B, Annovazzi POL, Comi G (2004) Therapy of primary hedaches: the role of antidepressant. Neurol Sci 25:S171–S175
Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS, European Federation of Neurological Societies (2009) EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol 16(9):968–981
Proietti Cecchin A, Mea E, Tullo V et al (2009) Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 30(Suppl 1):S101–S104
Nahas Z, Marangell LB, Husain MM et al (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097–1104
Conflict of interest
The authors declare that there is no actual or potential conflict of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moschiano, F., D’Amico, D., Canavero, I. et al. Migraine and depression: common pathogenetic and therapeutic ground?. Neurol Sci 32 (Suppl 1), 85–88 (2011). https://doi.org/10.1007/s10072-011-0545-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-011-0545-0